CompletedPhase 3

Canalith Repositioning Procedure for BPPV in Primary Care

Canada56 participantsStarted 2002-01

Plain-language summary

The purpose of this study is to see whether family doctors can treat benign paroxysmal positional vertigo (BPPV), or dizziness, using a procedure in the office. The study is looking at whether the treatment procedure cures the dizziness in more patients compared to patients that receive a "sham" or placebo procedure.

Who can participate

Age range18 Years – 105 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * confirmed BPPV by positive Dix-Hallpike test Exclusion Criteria: * · Positive results of the Dix-Hallpike maneuver in both right and left head-hanging position; * Evidence of ongoing central nervous system disease (e.g., transient ischemic attack); * Otitis media; * Osteosclerosis; * Inability to tolerate a diagnostic Dix-Hallpike head-hanging maneuver; * Severe degenerative disc disease of cervical spine; * Severe and uncontrolled angina or hypertension

What they're measuring

Self-reported resolution (affirmative response to question: "Do you feel that the dizziness has completely resolved?") of vertigo and/or a negative result of the Dix-Hallpike maneuver

Trial details

NCT IDNCT00182273

SponsorMcMaster University

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Benign Paroxysmal Positional Vertigo trials